Another study found that liraglutide and semaglutide improved glucose tolerance and insulin sensitivity, reduced body weight gain and excessive lipid accumulation, and enhanced muscle atrophy in a high-fat diet model of obesity by activating the SIRT1 pathway [188]. Here, INS is linked to Obesity.